Related Experiment Video
Updated: May 22, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Knowledge, attitude and practices of Saudi pharmacists regarding CVD risk factors and associated barriers
Md Sayeed Akhtar1, Sirajudeen Shaik Alavudeen1, Khalid Orayj1
1Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Alfaraa, Abha, Saudi Arabia.
Abstract:
Risk assessment for cardiovascular diseases (CVD) is fundamental to prevention, enabling early intervention when risks are recognized. This cross-sectional study focuses on evaluating the knowledge, attitude, practices and perceived barriers of Saudi pharmacists regarding CVD risk factors. A self-administered survey was employed to collect the responses from the participants over a period of four months. Approximately 91% of the participants had completed their graduations and 49.4% of the participants had an experience of less than 5 years. Only 23.1% and 40.1% of the participants reported possessing functional sphygmomanometer and glucometer in their pharmacies, respectively, as a point of care tools. A high level of positive attitude was significantly (P=0.014) associating the level of education. The study identified several barriers influencing the CVD prevention services during pharmaceutical care. The top three barriers were lack of time (66.4%), lack of privacy (58.6%) and lack of tools (59.9%). Despite inadequate knowledge and barriers, a favourable attitude CVD prevention was observed. Thus, pharmacists' CVD risk assessment and preventive hurdles must be addressed. In addition to the Ministry of Health (MoH)'s recent public policy measures, healthcare workers should receive ongoing education and training on CVD prevention and treatment.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors affecting Blood pressure
Physiological Factors:
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

